Although systemic lupus erythematosus (SLE) has traditionally been considered a disease of women, men may also be affected. Thirty of 261 patients (12%) with SLE seen in this hospital were men. Arthritis was less common as a first symptom in the men, although this group of patients had discoid lesions and serositis more often than the women. During the follow up a lower incidence of arthritis and malar rash and a higher incidence ofother skin complications including discoid lesions and subcutaneous lupus erythematosus was found in the men. The incidence of nephropathy, neurological disease, thrombocytopenia, vasculitis, and serositis, was similar in the two groups. No significant immunological differences were found between men and women. These features indicate that several gender associated clinical differences may be present in patients with SLE.
Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease of unk-nown aetiology. One of its most striking characteristics is its higher prevalence among young women, men rarely being affected.' Sex distribution before puberty and late in life does not show this marked female preponderance, however.2 Additionally, androgens confer a protective effect in experimental murine lupus.3 Some workers therefore consider that sex affects the susceptibility to and expression of SLE. 4 The question which arises is whether the clinical and immunological manifestations of SLE in men differ from those in women. This is important because examination of more homogeneous subsets, such as male patients, may allow for earlier diagnosis, better treatment, and more accurate prognosis. Several workers have addressed this problem with controversial results.' %8 This is probably due to the small numbers of affected men in the various studies.
To determine whether any relation between disease pattern and sex exists we have prospectively analysed the clinical manifestations and immunological features of 30 men from a series of 261 unselected patients with SLE with special emphasis on the clinical course during follow up.
Patients and methods

PATIENTS
We studied prospectively 261 patients with SLE who were seen consecutively at the Hospital Clinic of Barcelona either as inpatients or outpatients between 1980 and 1990. All were white and met the American Rheumatism Association revised criteria for SLE.9 Thirty (12%) were men and they represent the male group described in this paper. Follow up ranged between two months and 10 years (mean (SD) 64 (55) months) with no significant differences between the male and female groups.
A Two men and 10 women (7 v 4%; p=not significant) died during the follow up period of the survey. The causes of death in the men were lung carcinoma and a multisystem fungal infection. Table 3 gives the immunological findings in relation to sex. A positive titre of antinuclear antibodies and antibodies to double stranded DNA as well as hypocomplementaemia were common in the two groups, with a similar proportion of clinically active patients in both groups. No significant difference between men and women was found.
IMMUNOLOGICAL ABNORMALITIES
The prevalence of antiphospholipid antibodies (anticardiolipin antibodies or lupus anticoagulant, or both) was similar in the two groups of patients. In addition no significant Font, Cervera, Navarro, et al 7 Secondly, when we analysed the clinical manifestations during the follow up period we confirmed a lower incidence of arthritis and malar rash in the men and a higher incidence of discoid lesions, but we also found a higher incidence of subcutaneous lupus erythematosus. The incidence of nephropathy, neurological disease, thrombocytopenia, vasculitis, and serositis, was similar in the two groups. In addition no significant immunological differences were found between men and women.
The discrepancies between this and previous studies may be due to differences in the criteria that have been used for the diagnosis of the clinical manifestations or may reflect the effects of patient selection or ethnic and racial differences. Nevertheless, although this study could not confirm some of the differences found by other workers it does support the overall conclusion of previous workers that several gender associated differences in the clinical features of SLE may be present.
Although the explanation for this apparently sex related variability in SLE expression is still unclear, a possible key role of sex hormones in the pathogenesis of SLE has been postulated. Sex hormones may be important in modifying SLE expression and in facilitating or suppressing the disease. 8 Many questions still await further study from this hormonal perspective, however.
